2016
DOI: 10.3109/03009742.2016.1161070
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity

Abstract: When analysing sera from patients with RA with multiplex bead ELISA, the assay should be evaluated for interference by heterophilic antibodies, and if present corrected with, for example, HeteroBlock.

Search citation statements

Order By: Relevance

Paper Sections

Select...
8
5
4
2

Citation Types

2
16
0
0

Year Published

Range
2016
2016
2024
2024

Publication Types

Select...
15
1

Relationship

0
16

Authors

Journals

citations

Cited by 16 publications

(18 citation statements)
references

References 32 publications

2
16
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…In the 27-plex cytokine assay, our study revealed interference in 70% of tested sera, and 17 out of 27 cytokine assays. In line with other publications, our results showed that interference from RF can be reduced by addition of blocking agents [ 10 – 12 ]. We encourage the assay producer to protect these assays against interference from RF, e.g.…”
Section: Discussion
supporting
confidence: 93%
“…However, levels of RF IgA and IgM were only weakly correlated with the level of anti-animal IgG reactivity in our study, suggesting that antibody properties such as avidity and specificity could be equally important. In line with our results, other studies have shown that interference in multiplex cytokine assays is unpredictable in relation to RF level, and all sera from RA patients should be treated as likely to interfere in multiplex assays [ 10 , 12 ].…”
Section: Discussion
supporting
confidence: 90%
See 1 more Smart Citation